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Introduction
Both chronic fatigue (CF) connected to a chronic or seri-
ous disease, and Chronic Fatigue Syndrome (CFS) form a
serious problem in our Western society. It causes a lot of
suffering for patients and may lead to disability to work.
Doctors are frequently confronted with these patients, but
it is unknown how many of these patients are suffering
without help-seeking.
Most research has been done in CFS, and in specialised
CFS clinics. Much less is known about other types of
chronic fatigue, connected with a serious disabling dis-
ease, or with a psychiatric condition. There is hardly any
knowledge about the prevalence and characteristics of
these types of chronic fatigue and especially CFS, and the
course of CFS in the general population. If we would
know more about fatigue and chronic fatigue in the gen-
eral population then, for example, the development of
prevention programs would become nearer.
Both studies published in this Journal [1,2] give a lot of
interesting information about CF and CFS and the course
of CFS in the general population. It is interesting to look
at the differences between these studies and the data
found in studies with referred CFS patients and, looking at
the course of CFS, to discuss the possible implications for
the diagnostic criteria for CFS.
In the study of Solomon et al [1] a group of fatigued per-
sons was compared with a group of about the same size of
non-fatigued respondents, both from the general popula-
tion. The fatigued group was subdivided in prolonged
fatigue (fatigue between 1 and 6 months), chronic fatigue
(fatigue longer than 6 months but with insufficient symp-
toms to meet the case definition of CFS) and CFS-like
(respondents with self-reported sufficient fatigue severity
and symptoms). Within all 4 groups the authors looked at
the presence of medical or psychiatric conditions. Only
those medical or psychiatric conditions were asked for
that might explain the fatigue symptoms and thus exclude
a diagnosis of CFS. So there emerged 8 groups.
Chronic fatigue in the general population
In several studies it was shown that more women suffer
from CFS than men. One of the reasons could be that this
has to do more with help seeking behaviour and referral
bias than with gender. In that way of thinking one would
expect that fatigue in the general population is equally
divided in men and women. According to these two stud-
ies this seems not to be the case. Although the percentage
of females in the 8 groups is not explicitly mentioned,
with each level of fatigue, the preponderance of females
increases, with CFS showing the highest percent of
females (93%) [1]. In the other study the percentage of
female CFS subjects was 83% [2]. So the proportion of
females with CFS in the general population is not differ-
ent from tertiary care CFS patients.
The proportion females in chronic fatigue with medical
conditions is not explicitly mentioned, but seems higher
than we found in our studies in neuromuscular diseases
and in disease-free cancer patients, where we found no
relationship between gender and fatigue severity [3,4].
The reported onset of symptoms in CFS seems different in
the general population. More than 75% of the sample of
65 persons fulfilling the CFS criteria reported a gradual
onset. In most CFS studies in tertiary care only a small
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proportion of the patients (25%) report a gradual onset
(see for example ref. [5]).
Impairment in explained and unexplained 
chronic fatigue
Patients with so-called Explained Syndromic Fatigue
(people whose fatigue is associated with a known chronic
disabling condition), appeared to be as severely impaired
as CFS. But the unemployment rate in the ESF subjects is
even higher, namely 40%, compared to 15% unemploy-
ment due to fatigue in the CFS subjects. This is in contrast
with most CFS studies in tertiary care where higher per-
centages of unemployment are found. This means that
CFS patients in the general population, diagnosed as CFS
or not, are less severe impaired as far as employment is
concerned. It would be interesting to know whether there
is also a relationship with help seeking.
Fatigue as a continuum?
One cannot become chronic fatigued from one day to the
other. Only after 6 months of suffering one can speak of
CFS, if the other conditions are fulfilled. Does this mean
that CFS is the end of a continuum, running from acute,
short-term fatigue to long-term fatigue, and ultimately to
chronic fatigue and chronic fatigue syndrome? Or is CFS a
distinct disease entity not only quantitatively different (in
degree of fatigue, functional impairment and additional
symptoms) but also qualitatively different from the non-
CFS conditions?
From the here presented studies one can hardly sustain
the last option. The results in both studies seem to support
the notion that fatigue and chronic fatigue can best be
seen as a continuum, with CFS and Explained Syndromic
Fatigue at one end of this continuum. For example, in gen-
eral it is found that the more severe or the longer the
fatigue the more impairment is reported. Also the finding
that the CFS classification is not stable over time [2] fits
the idea of a continuum.
The problem of CFS case finding
Another remarkable finding is that of the 256 persons
with CFS-like characteristics who agreed to be clinically
evaluated, only 43 (17%) fulfilled the criteria for CFS.
This is a very low percentage. It is not commented by the
authors. If the interpretation of misclassification of CFS in
this study is less likely then it could be that CFS-like char-
acteristics by self-report do not predict the clinical diagno-
sis of CFS. If this is true then the conclusion is inevitable
that it is impossible to make estimations of CFS preva-
lence in epidemiological studies only 1 of CFS. This
would mean that valid epidemiological studies of CFS in
the general population without clinical evaluation of the
subjects are impossible. Anyway there is a need for an epi-
demiological CFS case-finding definition that corre-
sponds better with the clinical diagnosis of CFS.
Diagnosed CFS cases in the general population
One of the advantages of studies in the general population
is that there can be no referral bias. In the study of Solo-
mon et al [1] only 7 of the above mentioned 43 subjects
(16%) who fulfilled the criteria of CFS after clinical eval-
uation, were ever diagnosed as CFS in the past by a practi-
tioner. This is a very small number, asking for an
explanation.
There are at least two possible explanations.
1) Most subjects with CFS in the general population do
not seek help for their symptoms and are therefore never
diagnosed as such. These data are not available in this
study, so we also do not know why these subjects don't
seek help. It may be the same situation as in IBS patients.
Many subjects in the general population have IBS symp-
toms, but only a small proportion (25–38%) seeks help
for their complaints (e.g. ref. [6]).
2) CFS is too difficult to diagnose for most practitioners.
If it is assumed that the subjects with CFS visited practi-
tioners, it might be that the practitioner is not familiar
with the criteria for CFS [7] or that they do not understand
or accept their symptoms [8]. It is not mentioned in the
study [1] how many patients were diagnosed as CFS by a
doctor in the past, but do not fulfil the criteria for CFS
anymore at the moment of the study. That this is very well
possible is demonstrated the other study of the CDC
group [2].
It is a pity that the authors do not really try to explain or
analyse the low rate of CFS diagnosis in their study. We
have to wait for their next publication. They suggest that
persons with diagnosed CFS are quite different from the
undiagnosed. They also say that clinic-based samples may
not be generalizable to the CFS population. But that still
has to be demonstrated.
Course of CFS classification in the general 
population
In the study of Nisenbaum et al [2] the course of CFS in
the general population over a period of three years was
investigated. Persons who fulfilled the criteria for CFS by
self-report were asked to participate in a clinical evalua-
tion.
The most remarkable finding is that only one third of the
CFS subjects retained the classification of CFS at one year
follow-up, and only 21% at 2 and 3 years follow-up. And,
most striking, only 3 of the 40 (8%) subjects sustained the
CFS classification over two consecutive follow-ups.Health and Quality of Life Outcomes 2003, 1 http://www.hqlo.com/content/1/1/52
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Again, several explanations are possible. The non-consist-
ent CFS classification might mean that the course of CFS
in the general population is much more favourable than
CFS patients from tertiary care, considering the finding
that 57% of the sample experienced a partial or total
remission at the end of follow-up. Most subjects reported
reduced fatigue after the first visit. The figure of 57%
remission is higher than the 20–50% that is found in ter-
tiary care [9]. At the other side, only one quarter sustained
partial remission and 10% sustained total remission for
two consecutive periods. This figure cannot be compared
with tertiary care CFS patients, as sustained remission over
time have never been investigated in referred CFS patients.
One could also interpret these results as a support of the
notion that CFS (and perhaps the same is true for
Explained Syndromic Fatigue) is the end of a continuum
(see above). Subjects might fluctuate on this continuum.
At one moment subjects are at the end of this continuum,
fulfilling the criteria for CFS, and at other moments sub-
jects are before the end of the continuum, so not fulfilling
the CFS criteria. In this interpretation CFS, perhaps as a
consequence of the chosen definition, is not a stable con-
dition at all. Symptoms are fluctuating over time.
The authors interpret the low proportion of subject con-
sistently fulfilling the CFS criteria as a consequence of
their study design and suppose that clinical diagnosis is
less conservative. They assume that practitioners will con-
tinue to consider such persons as having CFS despite their
reduction in fatigue. This interpretation cannot be tested
in this study because there were hardly any subjects diag-
nosed or treated as CFS cases. The authors seem to refer to
a problem of the CFS case definition. They implicitly sug-
gest that there may be a difference between a research def-
inition of CFS (as the CDC-1994 definition is) and a
clinical definition for CFS. However, the problem is that
an empirical validation is lacking for all proposed defini-
tions of CFS [10] including a clinical definition of CFS
[11].
Remission not associated with any particular 
treatment
Currently only CBT and graded exercise therapy (GET)
have demonstrated evidence for efficacy in CFS. There is
no evidence of efficacy of complementary or alternative
medicine [3]. In this study also no relation between
fatigue reduction and the use of complementary or alter-
native medicine was found. This means that these types of
treatment should not be encouraged. Remission was not
associated with any particular treatment, which probably
means that the improvement is not the result of a specific
treatment.
According to the authors CBT or GET was not an available
treatment for the subjects in this study, so no relationship
could be found between CBT/GET and remission. Remis-
sion was also not associated with the report of being ever
diagnosed as CFS. Although the number of CFS diagnosed
subjects was very low, it may mean that the diagnosis of
CFS cannot be seen as unfavourable for remission. This is
contrary the idea of some family doctors who are reluctant
to diagnose their patients as having CFS, as they are afraid
that this will facilitate an unfavourable course of the con-
dition.
This finding and the availability of a possible effective
treatment, together with the finding that sustained remis-
sion was associated with a shorter illness duration, is a
plea to diagnose CFS as early as possible. Hopefully, the
interesting questions these two studies in the general pop-
ulation evoke will stimulate more studies of fatigue in the
general population.
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